Edwards Lifesciences Closed Now

Edwards Lifesciences is a global medical technology company specializing in structural heart disease and critical care monitoring. Founded in 1958, the company is best known for pioneering innovations in heart valve therapy, particularly transcatheter aortic valve replacement (TAVR) technologies that have transformed the treatment of valvular heart disease.

Edwards Lifesciences operates in more than 100 countries, working closely with cardiac surgeons, interventional cardiologists, and healthcare institutions to deliver life-saving cardiovascular solutions.

Mission and Vision

• Mission: To help patients live longer, healthier, and more productive lives through innovative cardiovascular and critical care technologies.

• Vision: To be the global leader in structural heart and critical care solutions, setting the standard for patient-focused innovation and clinical excellence.

Products and Services

1. Structural Heart

Edwards Lifesciences is the world leader in transcatheter heart valve therapies, including:

• SAPIEN™ Transcatheter Heart Valve Family (TAVR/TAVI)

• Transcatheter mitral and tricuspid valve repair and replacement systems

• Surgical heart valves (tissue and mechanical valves)

These technologies enable minimally invasive alternatives to open-heart surgery.

2. Critical Care Monitoring

Advanced hemodynamic monitoring solutions for intensive care units and operating rooms:

• Swan-Ganz™ catheters

• FloTrac™ and EV1000™ platforms

• Advanced patient monitoring systems for cardiac output and tissue perfusion

These systems support real-time, data-driven clinical decision-making.

Technology & Innovation

Edwards Lifesciences invests heavily in R&D focused on:

• Next-generation transcatheter valve platforms

• Minimally invasive cardiovascular therapies

• Advanced hemodynamic analytics

• AI-enabled patient monitoring systems

• Biocompatible materials and tissue engineering

The company maintains one of the strongest clinical evidence portfolios in the cardiovascular device industry.

Global Impact

Edwards Lifesciences’ technologies have been used to treat millions of patients worldwide, particularly those who were previously considered inoperable or high-risk for surgery.

• Active in 100+ countries

• Leader in structural heart therapy adoption

• Extensive physician training and clinical education programs

• Strong partnerships with leading cardiac centers globally

Its innovations continue to redefine standards of care in heart valve therapy and critical care medicine.